Parkinson's affects more than 1 million people in the US. Only 10 to 20% of people with Parkinson's experience symptoms ...

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...

The progression of Parkinson's disease often requires a change of therapy. An expert explains when this should be done and ...

Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

Anticholinergics and injection of botulinum toxin into the salivary glands are therapeutic options ... the treatment of erectile dysfunction in PD. Clinical diagnosis of Parkinson's disease ...

“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...

A study from the University of Arizona shows that the protein PNA5 helps protect brain cells, offering a promising avenue for ...

Intra-Cellular Therapies is developing Lenrispodun for the treatment of patients with Parkinson's Disease in a phase 2 study.

This report offers insights into recent health news, encompassing advancements in Parkinson's and cancer treatments, ...

I’ve described Parkinson’s as an “unforgiving” disease and a “slow crawl into the brambles.” Kathy is the love of my life.

Treatment with tavapadon led to a statistically significant improvement in motor function compared with placebo. Topline results were announced from a phase 3 trial evaluating tavapadon, a selective ...